Stay updated on CaboNivo for Locally Advanced HCC Clinical Trial
Sign up to get notified when there's something new on the CaboNivo for Locally Advanced HCC Clinical Trial page.

Latest updates to the CaboNivo for Locally Advanced HCC Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoChange DetectedThe record now displays detailed information about the completed phase 1 study of cabozantinib plus nivolumab for locally advanced hepatocellular carcinoma, including its eligibility criteria, treatment plan, and measured outcomes. It also includes study contacts, collaborators, publications, and record dates.SummaryDifference49%

- Check16 days agoChange DetectedA site-wide NIH announcement about website changes and terminology now appears above the 403 error page. The footer revision label changed from v3.7.2 to v3.8.0.SummaryDifference1%

- Check30 days agoChange DetectedThe footer revision number changes from v3.7.1 to v3.7.2.SummaryDifference0.2%

- Check37 days agoChange DetectedThe footer revision identifier changes from v3.7.0 to v3.7.1 while the study page continues to show a 403 Forbidden error.SummaryDifference0.2%

- Check57 days agoChange DetectedThe page now displays a 403 Forbidden error, blocking the study record content while the header and footer remain visible.SummaryDifference18%

- Check78 days agoChange DetectedThe page's revision tag was updated from v3.6.5 to v3.6.6, indicating a small version update to the page metadata.SummaryDifference0.1%

Stay in the know with updates to CaboNivo for Locally Advanced HCC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CaboNivo for Locally Advanced HCC Clinical Trial page.